throbber
5/4/2016
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home3 Drug Databases‘ Orange Books
`
`Orange Book: Agproved Dru Products with Therapeutic Equivalence Evaiuations
`Orange Book Search esults on paten number '8859623' in the OB_Rx list.
`
`
`
`’ Code
`
`Claim
`
`
`
`5
`
`..
`.
`5 Substance
`3 Claim
`V
`
`
`
`,.
`
`lg
`
`
`
`.8859623
`
`NOV 14, 2033
`
`8859623
`
`..
`
`'
`
`5
`
`N203510
`
`N203510
`
`
`i
`D01
`
`i002
`
`Additional information:
`
`PHENYLEPHRlNE
`HYDROCHLORIDE
`
`PHENYLEPHRINE
`HYDROCHLORIDE
`
`>NOV 14, 2033
`
`
`
`1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
`2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be
`flagged with respect to other claims which may apply.
`View a list of all patent use codes
`
`Retum to Electronic Orange Book Home Pages
`FDA/Center for Drug Evaluation and Research
`Office of Generic Dmgs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Dmg Product Information & Patent Information - Daily
`Orange Book Data Updated Through March 2016
`Patent and Generic Drug Product Data Last Updated May 04, 2016
`
`Links on this page:
`1 . http:Jlwww.addthis.com/bookmark.php?u508=true&v=152&usemame=fdamain
`
`2. http://www.addthis.com/bookmark.php
`
`3. http://www.fda.gov/default.htm
`
`4. http:iIwww.fda.gov/Drugsil nformationOnDrugs/default.htm
`5. ../default.cfm
`
`6. ../default.cfm
`
`Note: if you need help accessing information in different file formats, see lnstmctions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No FEAR Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`
`E
`’T§a.,e~_.v.,.
`For Govemment For Press
`
`
`
`Combination Products Advisory Committees Science & Research Regulatory lnforrnation Safety Emergency Preparedness lntemational Programs News &
`Events Training and Continuing Education Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`£ U.S.€!eper3:ment of fleaittz 8: Human Services
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php'?u508=tn.ie&v=152&usemame=fdamain
`
`2. http://www.addthis.com/bookmark.php
`
`3. http://www.fda.gov/default.htm
`
`4. http://wwvv.fda.gov/Drugs/lnformationOnDnigs/defauithtm
`5. ../defaultcfm
`
`6. ../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/newobpatcfm
`
`Page 1 of 5
`
`1/1
`
`Exhibit 1035, Page 1 of 5
`
`

`
`5/4/2016
`
`Oranm Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home3 Drug Databases4 Orange Book5
`
`Oran e Book: Approved Drug Products with Therapeutic Equivalence Evaiuations
`Searc resuits from the "OB_Rx ' table for query on "203510."
`
`Active Ingredient:
`
`Dosage Form ;Route:
`
`Proprietary Name:
`
`Applicant:
`
`Strength:
`
`Application Number:
`Product Number:
`
`Approval Date:
`
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`
`PHENYLEPHRENE HYDROCHLORIDE
`
`SOLUTION/DROPS;OPHTHALMIC
`
`PHENYLEPHRINE HYDROCHLORIDE
`
`PARAGON BIOTECK
`
`2.5%
`
`N20351O
`001
`
`Mar 21, 2013
`
`Yes
`RX
`
`Patent and Exclusivity Info for this product: View
`
`Active Ingredient:
`
`Dosage Form;Route:
`
`Proprietary Name:
`
`Applicant:
`
`Strength:
`
`Application Number:
`Product Number:
`
`Approval Date:
`
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`
`PHENYLEPHRINE HYDROCHLORIDE
`
`SOLUTION/DROPS;OPHTHALMIC
`
`PHENYLEPHRINE HYDROCHLORIDE
`
`PARAGON BIOTECK
`
`1 0%
`
`N20351O
`002
`
`Mar 21, 2013
`
`Yes
`RX
`
`Patent and Exclusivity Info for this productzview
`
`Return to Electronic Orange Book Home Page5
`
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeiing and Program Support
`Update Frequency:
`
`Orange Book Data — Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through March 2016
`Patent and Generic Drug Product Data Last Updated May 04, 2016
`
`Links on this page:
`
`1 2 3 4
`
`. http://www.addthis.com/bookmark.php?uS08=true&v=152&username=fdamain
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`5 6
`
`. ../default.cfm
`
`. ../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cderlob/docs/obdetaiI.cfm'?Appl_No=203510&TABLE1=OB_Rx
`
`Exhibit 1035, Page 2 of 5
`
`1/2
`
`Exhibit 1035, Page 2 of 5
`
`

`
`5/4/2016
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading
`Viewers and Players.
`
`Accessibility Contact FDA Careers FDA Basics FOIA No FEAR Act Site Map Transparency Website
`Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888—INFO—FDA (1-888-463-6332)
`Contact FDA
`
`
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`U3. Eeparhrbeni of Haaltit 5: Human
`
`Links on this page:
`
`1 2 3 4
`
`. http://www.addthis.com/bookmark.php?u508=true&v=152&usemame=fdamain
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`5.
`
`../default.cfm
`
`6 .
`
`../default.cfm
`
`http://www.accessdata.fda.govIscriptsloderlobldocslobdetail.cfm?Appl_No=203510&TABLE1=OB_Rx
`
`Exhlblt 1035, Page 3 Of 5
`
`2/2
`
`Exhibit 1035, Page 3 of 5
`
`

`
`5/4/2016
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home?’ Drug Databases4 Orange Book5
`
`Oran e Book: Approved Drug Products with Therapeutic Equivalence Evaiuations
`Searc results from the "OB_Rx ' table for query on "203510."
`
`Active Ingredient:
`
`Dosage Form;Route:
`
`Proprietary Name:
`
`Applicant:
`
`Strength:
`
`Application Number:
`Product Number:
`
`Approval Date:
`
`Reference Listed Drug
`RX/OTC/DISCN :
`TE Code:
`
`PHENYLEPHRINE HYDROCHLORIDE
`
`SOLUTION/DROPS;OPHTHALMIC
`
`PHENYLEPHRINE HYDROCHLORIDE
`
`PARAGON BIOTECK
`
`2.5%
`
`N20351O
`001
`
`Mar 21, 2013
`
`Yes
`RX
`
`Patent and Exclusivity Info for this product: View
`
`Active Ingredient:
`
`Dosage Form ;Route:
`
`Proprietary Name:
`
`Applicant:
`
`Strength:
`
`Application Number:
`Product Number:
`
`Approval Date:
`
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`
`PHENYLEPHRINE HYDROCHLORIDE
`
`SOLUTION/DROPS;OPHTHALMIC
`
`PHENYLEPHRINE HYDROCHLORIDE
`
`PARAGON BIOTECK
`
`10%
`
`N203510
`002
`
`Mar 21, 2013
`
`Yes
`RX
`
`Patent and Exclusivity Info for this product: View
`
`Return to Electronic Orange Book Home Pages
`
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through March 2016
`Patent and Generic Drug Product Data Last Updated May 04, 2016
`
`
`Links on this page:
`
`1 2 3 4
`
`. http://www.addthis.com/bookmark.php?uS08=true&v=152&username=fdamain
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`5 6
`
`. ../defaultcfm
`
`.
`
`../default.cfm
`
`http:/Iwww.accessdata.fda.govlscripts/cderlob/docs/obdetail.cfm?App|_No=203510&TABLE1=0B_Rx
`
`Exhibit 1035, Page 4 of 5
`
`1/2
`
`Exhibit 1035, Page 4 of 5
`
`

`
`5/4/2016
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading
`Viewers and Players.
`
`Accessibility Contact FDA Careers FDA Basics FOIA No FEAR Act Site Map Transparency Website
`Policies
`<
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO—FDA ( 1-888-463-6332)
`
`
`
`For Government For Press
`
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`3.5. Department of Haalfis xii.
`
`Links on this page:
`
`1 2 3 4
`
`. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`
`. http://www.addthis.com/bookmark.php
`
`. http://www.fda.gov/default.htm
`
`. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`
`5.
`
`../default.cfm
`
`6 .
`
`../default.cfm
`
`htlp:llwww.accessdata.fda.gov/scripts/cderlob/docs/obdetail.cfm?App|_No=203510&TABLE1=OB_Rx
`
`Exhibit 1035, Page 5 of 5
`
`2/2
`
`Exhibit 1035, Page 5 of 5

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket